Our global life sciences company brings diagnostic testing & drug development together.
Mutational data to guide regimen switches in suppressed patients
To assess NS5A drug susceptibility in patients with Hepatitis C
Combined phenotype and genotype test to guide treatment decision in treatment-experienced patients
Has utility in assessing HBV replication in the absence and presence of antiviral therapy
Monogram Biosciences is a valued research partner committed to our biopharmaceutical partners and research collaborators.